1. Home
  2. FOLD vs REZI Comparison

FOLD vs REZI Comparison

Compare FOLD & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • REZI
  • Stock Information
  • Founded
  • FOLD 2002
  • REZI 2018
  • Country
  • FOLD United States
  • REZI United States
  • Employees
  • FOLD N/A
  • REZI N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • REZI Wholesale Distributors
  • Sector
  • FOLD Health Care
  • REZI Industrials
  • Exchange
  • FOLD Nasdaq
  • REZI Nasdaq
  • Market Cap
  • FOLD 2.9B
  • REZI 2.7B
  • IPO Year
  • FOLD 2007
  • REZI N/A
  • Fundamental
  • Price
  • FOLD $6.16
  • REZI $20.61
  • Analyst Decision
  • FOLD Buy
  • REZI Hold
  • Analyst Count
  • FOLD 10
  • REZI 1
  • Target Price
  • FOLD $16.22
  • REZI $16.00
  • AVG Volume (30 Days)
  • FOLD 5.0M
  • REZI 966.6K
  • Earning Date
  • FOLD 05-01-2025
  • REZI 05-06-2025
  • Dividend Yield
  • FOLD N/A
  • REZI N/A
  • EPS Growth
  • FOLD N/A
  • REZI N/A
  • EPS
  • FOLD N/A
  • REZI 0.30
  • Revenue
  • FOLD $543,141,000.00
  • REZI $7,045,000,000.00
  • Revenue This Year
  • FOLD $19.85
  • REZI $11.43
  • Revenue Next Year
  • FOLD $23.50
  • REZI $3.45
  • P/E Ratio
  • FOLD N/A
  • REZI $68.16
  • Revenue Growth
  • FOLD 28.25
  • REZI 14.02
  • 52 Week Low
  • FOLD $5.81
  • REZI $14.18
  • 52 Week High
  • FOLD $12.65
  • REZI $28.28
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 41.91
  • REZI 61.38
  • Support Level
  • FOLD $6.03
  • REZI $19.65
  • Resistance Level
  • FOLD $6.37
  • REZI $20.92
  • Average True Range (ATR)
  • FOLD 0.24
  • REZI 0.45
  • MACD
  • FOLD 0.04
  • REZI -0.09
  • Stochastic Oscillator
  • FOLD 41.67
  • REZI 46.83

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: